Evaggelia Ktena

Evaggelia Ktena has a strong background in research and development (R&D) within the pharmaceutical industry. Evaggelia started their career at Elpen Pharmaceutical Co. Inc. in 2017, where they initially served as an R&D Respiratory Analyst. In this role, they were responsible for analytical method development and validation for inhalation generic drugs, as well as conducting forced degradation studies and in-vitro development testing. Evaggelia also supported new product development and maintained documentation and compliance with regulatory requirements.

Evaggelia then progressed to the position of Senior R&D Respiratory Analyst at Elpen Pharmaceutical Co. Inc. in September 2021. In this role, they managed a team of analysts and supervised analytical activities and schedules. Evaggelia was responsible for R&D analytical operations, including product development and analytical method transfer. Evaggelia prioritized analytical processes to meet deadlines and targets, participated in R&D meetings, and collaborated with various departments for approvals. Evaggelia also conducted direct report reviews and implemented corrective actions. Additionally, they selected suppliers to assist R&D activities and evaluated offers under budget and quality constraints.

Prior to their work at Elpen Pharmaceutical Co. Inc., Evaggelia gained experience as an R&D Researcher at QualiMetrix S.A. in 2016 and as an Analytical Researcher at Charles University in Prague from 2014 to 2015.

Overall, Evaggelia Ktena has a proven track record in R&D within the pharmaceutical industry, with expertise in analytical method development, product development, and regulatory compliance.

Evaggelia Ktena holds a diverse educational background spanning various disciplines. In 2020 to 2022, they pursued a Master of Business Administration (MBA) degree in Business Administration and Management, General from Hellenic Open University. Prior to this, from 2015 to 2017, Evaggelia attended National & Kapodistrian University of Athens, where they obtained a Master of Science (MS) degree in Chemical Analysis - Quality Control (Pharmaceuticals). Evaggelia had previously completed their Bachelor's Degree in Chemistry at the same university from 2011 to 2015.

Furthermore, Evaggelia possesses a Diploma degree in piano from the International Conservatory in Athens, which they earned from 2006 to 2014.

In addition to their formal education, they have also acquired several certifications. In 2019, they completed the "Maintaining ACQUITY UPLC Systems and Troubleshooting Training" program offered by Waters Corporation. In 2018, Evaggelia received training in MS/MS (Mass Spectrometry) in Vienna through Waters Corporation. Additionally, they hold a Microsoft Office Certification (ECDL), which they obtained in 2017 from the ECDL Foundation.